These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29453225)

  • 1. Prevalence of age-related macular degeneration associated genetic risk factors and 4-year progression data in the Irish population.
    Connolly E; Rhatigan M; O'Halloran AM; Muldrew KA; Chakravarthy U; Cahill M; Kenny RA; Doyle SL
    Br J Ophthalmol; 2018 Dec; 102(12):1691-1695. PubMed ID: 29453225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans.
    Contreras AV; Zenteno JC; Fernández-López JC; Rodríguez-Corona U; Falfán-Valencia R; Sebastian L; Morales F; Ochoa-Contreras D; Carnevale A; Silva-Zolezzi I
    Mol Vis; 2014; 20():105-16. PubMed ID: 24453474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic variants rs641153 (
    Neto JM; Viturino MG; Ananina G; Bajano FF; Costa SMDS; Roque AB; Borges GF; Franchi R; Rim PH; Medina FM; Costa FF; Melo MB; de Vasconcellos JP
    Exp Biol Med (Maywood); 2021 Nov; 246(21):2290-2296. PubMed ID: 34233521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort.
    Joachim N; Mitchell P; Rochtchina E; Tan AG; Wang JJ
    Ophthalmology; 2014 Apr; 121(4):917-25. PubMed ID: 24332537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
    Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
    JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population.
    Buentello-Volante B; Rodriguez-Ruiz G; Miranda-Duarte A; Pompa-Mera EN; Graue-Wiechers F; Bekker-Méndez C; Ayala-Ramirez R; Quezada C; Rodríguez-Loaiza JL; Zenteno JC
    Mol Vis; 2012; 18():2518-25. PubMed ID: 23112567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.
    Domalpally A; Agrón E; Pak JW; Keenan TD; Ferris FL; Clemons TE; Chew EY
    Ophthalmology; 2019 Dec; 126(12):1659-1666. PubMed ID: 31558345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.
    Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ;
    JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study.
    Joachim N; Mitchell P; Burlutsky G; Kifley A; Wang JJ
    Ophthalmology; 2015 Dec; 122(12):2482-9. PubMed ID: 26383995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.
    Seddon JM; Reynolds R; Maller J; Fagerness JA; Daly MJ; Rosner B
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2044-53. PubMed ID: 19117936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in five genes and the severity of age-related macular degeneration: results from the Muenster aging and retina study.
    Farwick A; Dasch B; Weber BH; Pauleikhoff D; Stoll M; Hense HW
    Eye (Lond); 2009 Dec; 23(12):2238-44. PubMed ID: 19169232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Progression, and Associated Risk Factors of Medium Drusen in Age-Related Macular Degeneration: Findings From the 15-Year Follow-up of an Australian Cohort.
    Joachim ND; Mitchell P; Kifley A; Wang JJ
    JAMA Ophthalmol; 2015 Jun; 133(6):698-705. PubMed ID: 25838066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration.
    van de Ven JP; Smailhodzic D; Boon CJ; Fauser S; Groenewoud JM; Chong NV; Hoyng CB; Klevering BJ; den Hollander AI
    Mol Vis; 2012; 18():2271-8. PubMed ID: 22933840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility genes and progression in age-related maculopathy: a study of single eyes.
    Farwick A; Wellmann J; Stoll M; Pauleikhoff D; Hense HW
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):731-6. PubMed ID: 19797206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association of neovascular age-related macular degeneration with polymorphisms of CFH, ARMS2, HTRA1 and C3 genes in Czech population.
    Matušková V; Zeman T; Ewerlingová L; Hlinomazová Z; Souček J; Vlková E; Goswami N; Balcar VJ; Šerý O
    Acta Ophthalmol; 2020 Sep; 98(6):e691-e699. PubMed ID: 31970928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
    Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.
    Klein R; Myers CE; Meuer SM; Gangnon RE; Sivakumaran TA; Iyengar SK; Lee KE; Klein BE
    JAMA Ophthalmol; 2013 Mar; 131(3):383-92. PubMed ID: 23494043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype.
    Loane E; Nolan JM; McKay GJ; Beatty S
    Exp Eye Res; 2011 Nov; 93(5):592-8. PubMed ID: 21816153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extramacular drusen are highly associated with age-related macular degeneration, but not with CFH and ARMS2 genotypes.
    Ersoy L; Schick T; de Graft D; Felsch M; Hoyng CB; den Hollander AI; Kirchhof B; Fauser S; Liakopoulos S
    Br J Ophthalmol; 2016 Aug; 100(8):1047-51. PubMed ID: 26614632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.